SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-15-005013
Filing Date
2015-06-11
Accepted
2015-06-11 06:03:30
Documents
1
Period of Report
2015-03-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A ctic-8ka_20150323.htm 8-K/A 25685
  Complete submission text file 0001564590-15-005013.txt   26826
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12465 | Film No.: 15924779
SIC: 2834 Pharmaceutical Preparations